PEDIATRICS Vol. 13 No. 1 January 1954, pp. 44-58
This Article
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRICK, P. G.
Right arrow Articles by MCQUARRIE, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRICK, P. G.
Right arrow Articles by MCQUARRIE, I.

CONGENITAL AFIBRINOGENEMIA

PAUL G. FRICK M.D.1 and IRVINE MCQUARRIE M.D.2

1 The Department of Internal Medicine, University of Minnesota Hospitals, Minneapolis.
2 The Department of Pediatrics, University of Minnesota Hospitals, Minneapolis.

A case of congenital afibrinogenemia is described. Despite the absolute incoagulability of afibrinogenemic blood, this type of hemorrhagic diathesis is not accompanied by hemarthrosis.

Systematic studies of this patient's blood revealed that all other known clotting factors are present in normal concentration.

Comparison of the electrophoretic patterns of afibrinogenemic plasma and serum confirmed the fact that except for fibrinogen no other clotting factor is detectable by routine electrophoretic analysis. This is due to the extremely small concentration of these entities when compared with the value of total serum proteins.

On the basis of family studies the hereditary pattern of congenital afibrinogenemia is assumed to be recessive and not sex-linked.

The rate of disappearance of fibrinogen from the blood stream after transfusion of Cohn's Fraction I has been studied. Starting from a level of 161 mg./100 cc., the zero level was reached in 12 days.

Submitted on July 5, 1953